Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Surrozen Inc
SRZNCurrent price
13.23 USD
-0.75 USD (-5.36%)
Last closed
13.44 USD
Company
www.surrozen.com
ISIN
US86889P1093
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
33 340 826 USD
Yield for 12 month
+105.59 %
1Y
3Y
5Y
10Y
15Y
SRZN
Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California. Address: 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
33 USDP/E ratio
–Dividend Yield
–Current Year
+12 500 000 USD
Last Year
+12 500 000 USD
Current Quarter
–
Last Quarter
+4 146 000 USD
Current Year
-27 230 000 USD
Last Year
+12 500 000 USD
Current Quarter
-386 000 USD
Last Quarter
-392 000 USD
Key Figures SRZN
1 year
3 years
5 years
10 years
EBITDA
-35 835 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-43.03 %
PEG Ratio
–
Return On Equity TTM
-174.9 %
Wall Street Target Price
33 USD
Revenue TTM
12 500 000 USD
Book Value
1.89 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-22.49 USD
Diluted Eps TTM
-22.49 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SRZN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SRZN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
14.12.2023
Dividend Date
–
Stock Valuation SRZN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
1.7834
Enterprise Value EBITDA
0.7066
Price Book MRQ
5.2832
Financials SRZN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SRZN
For 52 weeks
4.5 USD
16.19 USD
50 Day MA
9.64 USD
Shares Short Prior Month
49 635
200 Day MA
10.14 USD
Short Ratio
3.4
Shares Short
44 460
Short Percent
1.87 %
BeatStart